These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4005584)

  • 21. Comparative biochemical and behavioural effects of fencamfamine and dl-amphetamine in rats.
    Aizenstein ML; Scavone C; Bernardi MM; Delucia R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):187-94. PubMed ID: 6684314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.
    Zetterström T; Sharp T; Marsden CA; Ungerstedt U
    J Neurochem; 1983 Dec; 41(6):1769-73. PubMed ID: 6196446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesolimbic dopamine and early post-6-OHDA lesion enhanced responses to d-amphetamine.
    Lynch MR; Carey RJ
    Pharmacol Biochem Behav; 1989 Feb; 32(2):577-80. PubMed ID: 2498910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat.
    Matthews RT; Shore PA
    Biochem Pharmacol; 1984 Sep; 33(17):2817-9. PubMed ID: 6466390
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate.
    Ewing AG; Wightman RM; Dayton MA
    Brain Res; 1982 Oct; 249(2):361-70. PubMed ID: 6814706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infusions of 6-hydroxydopamine into the nucleus accumbens abolish the analgesic effect of amphetamine but not of morphine in the formalin test.
    Clarke PB; Franklin KB
    Brain Res; 1992 May; 580(1-2):106-10. PubMed ID: 1504789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
    Suaud-Chagny MF; Buda M; Gonon FG
    Eur J Pharmacol; 1989 May; 164(2):273-83. PubMed ID: 2788097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge.
    Birgner C; Kindlundh-Högberg AM; Nyberg F; Bergström L
    Neurosci Lett; 2007 Jan; 412(2):168-72. PubMed ID: 17123707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of direct and indirect dopamine agonists on brain extracellular ascorbate levels in the striatum and nucleus accumbens of awake rats.
    Phebus LA; Roush ME; Clemens JA
    Life Sci; 1990; 47(15):1317-23. PubMed ID: 1978214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
    Quintanilla ME; Bustamante D; Tampier L; Israel Y; Herrera-Marschitz M
    Eur J Pharmacol; 2007 Nov; 573(1-3):84-92. PubMed ID: 17651729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
    Rivest R; Marsden CA
    Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-range differential pulse voltammetry for fast, selective analysis of basal levels of cerebral compounds in vivo.
    Crespi F; Möbius C; Neudeck A
    J Neurosci Methods; 1993 Nov; 50(2):225-35. PubMed ID: 7509018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT3 receptor antagonist ondansetron does not alter effects of amphetamine on DA metabolism.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B; Virtanen R
    Neuroreport; 1990 Oct; 1(2):126-8. PubMed ID: 2151795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain.
    Jackson DM; Andén NE; Dahlström A
    Psychopharmacologia; 1975 Dec; 45(2):139-49. PubMed ID: 1215445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo selective monitoring of basal levels of cerebral dopamine using voltammetry with Nafion modified (NA-CRO) carbon fibre micro-electrodes.
    Crespi F; Möbius C
    J Neurosci Methods; 1992 May; 42(3):149-61. PubMed ID: 1501500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in monoamine metabolites measured by simultaneous in vivo differential pulse voltammetry and intracerebral dialysis.
    Sharp T; Maidment NT; Brazell MP; Zetterström T; Ungerstedt U; Bennett GW; Marsden CA
    Neuroscience; 1984 Aug; 12(4):1213-21. PubMed ID: 6207457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACTH1-24 effects on d-amphetamine self-administration and the dynamics of brain dopamine in rats.
    Leccese AP; Lyness WH
    Prog Clin Biol Res; 1985; 192():71-81. PubMed ID: 3001772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6-Hydroxydopamine lesions of the olfactory tubercle do not alter (+)-amphetamine-conditioned place preference.
    Clarke PB; White NM; Franklin KB
    Behav Brain Res; 1990 Jan; 36(1-2):185-8. PubMed ID: 2105735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.